The outcome of COVID-19 in patients with hematological malignancy

被引：3
|
作者：
Yigenoglu, Tugce N. [1 ,2 ]
Basci, Semih [1 ,2 ]
Dal, Mehmet S. [1 ,2 ]
Korkmaz, Serdal [3 ]
Turgut, Burhan [4 ]
Altuntas, Fevzi [1 ,2 ,5 ]
机构：
[1] Univ Hlth Sci, Ankara Oncol Training & Res Hosp, Dept Hematol, Ankara, Turkey
[2] Univ Hlth Sci, Ankara Oncol Training & Res Hosp, Bone Marrow Transplantat Ctr, Ankara, Turkey
[3] Univ Hlth Sci, Kayseri Training & Res Hosp, Dept Hematol, Kayseri, Turkey
[4] Namik Kemal Univ, Dept Internal Med, Sch Med, Div Hematol, Tekirdag, Turkey
[5] Yildirim Beyazit Univ, Dept Internal Med, Sch Med, Div Hematol, Ankara, Turkey
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 03期
关键词：
D O I：
10.1002/jmv.26607
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1255 / 1255
页数：1
相关论文
共 50 条
  • [1] The outcome of COVID-19 in patients with hematological malignancy
    Yigenoglu, Tugce N.
    Ata, Naim
    Altuntas, Fevzi
    Basci, Semih
    Dal, Mehmet Sinan
    Korkmaz, Serdal
    Namdaroglu, Sinem
    Basturk, Abdulkadir
    Hacibekiroglu, Tuba
    Dogu, Mehmet H.
    Dal, Kursat
    Erkurt, Mehmet A.
    Turgut, Burhan
    Ulgu, Mustafa Mahir
    Celik, Osman
    Imrat, Ersan
    Birinci, Suayip
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 1099 - 1104
  • [2] The outcome of COVID-19 in patients with hematological malignancy
    Pınar Tığlıoğlu
    Murat Albayrak
    Mesut Tığlıoğlu
    Hacer Berna Afacan Öztürk
    Merih Reis Aras
    Buğra Sağlam
    Senem Maral
    memo - Magazine of European Medical Oncology, 2022, 15 : 83 - 89
  • [3] The outcome of COVID-19 in patients with hematological malignancy
    Tiglioglu, Pinar
    Albayrak, Murat
    Tiglioglu, Mesut
    Ozturk, Hacer Berna Afacan
    Aras, Merih Reis
    Saglam, Bugra
    Maral, Senem
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (01) : 83 - 89
  • [4] Hematological Malignancy Patients, COVID-19, and Favipiravir
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (04) : 331 - 332
  • [5] Risk factors and outcome of COVID-19 in patients with hematological malignancies
    Pinana, Jose Luis
    Martino, Rodrigo
    Garcia-Garcia, Irene
    Parody, Rocio
    Morales, Maria Dolores
    Benzo, Gonzalo
    Gomez-Catalan, Irene
    Coll, Rosa
    De la Fuente, Ignacio
    Luna, Alejandro
    Merchan, Beatriz
    Chinea, Anabelle
    de Miguel, Dunia
    Serrano, Ana
    Perez, Carmen
    Diaz, Carola
    Lopez, Jose Luis
    Saez, Adolfo Jesus
    Bailen, Rebeca
    Zudaire, Teresa
    Martinez, Diana
    Jurado, Manuel
    Calbacho, Maria
    Vazquez, Lourdes
    Garcia-Cadenas, Irene
    Fox, Laura
    Pimentel, Ana I.
    Bautista, Guiomar
    Nieto, Agustin
    Fernandez, Pascual
    Vallejo, Juan Carlos
    Solano, Carlos
    Valero, Marta
    Espigado, Ildefonso
    Saldana, Raquel
    Sisinni, Luisa
    Ribera, Josep Maria
    Jimenez, Maria Jose
    Trabazo, Maria
    Gonzalez-Vicent, Marta
    Fernandez, Noemi
    Talarn, Carme
    Montoya, Maria Carmen
    Cedillo, Angel
    Sureda, Anna
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2020, 9 (01)
  • [6] Risk factors and outcome of COVID-19 in patients with hematological malignancies
    José Luis Piñana
    Rodrigo Martino
    Irene García-García
    Rocío Parody
    María Dolores Morales
    Gonzalo Benzo
    Irene Gómez-Catalan
    Rosa Coll
    Ignacio De La Fuente
    Alejandro Luna
    Beatriz Merchán
    Anabelle Chinea
    Dunia de Miguel
    Ana Serrano
    Carmen Pérez
    Carola Diaz
    José Luis Lopez
    Adolfo Jesús Saez
    Rebeca Bailen
    Teresa Zudaire
    Diana Martínez
    Manuel Jurado
    María Calbacho
    Lourdes Vázquez
    Irene Garcia-Cadenas
    Laura Fox
    Ana I. Pimentel
    Guiomar Bautista
    Agustin Nieto
    Pascual Fernandez
    Juan Carlos Vallejo
    Carlos Solano
    Marta Valero
    Ildefonso Espigado
    Raquel Saldaña
    Luisa Sisinni
    Josep Maria Ribera
    Maria Jose Jimenez
    Maria Trabazo
    Marta Gonzalez-Vicent
    Noemí Fernández
    Carme Talarn
    Maria Carmen Montoya
    Angel Cedillo
    Anna Sureda
    Experimental Hematology & Oncology, 9
  • [7] Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
    Ikeda, Daisuke
    Terao, Toshiki
    Fukumoto, Ami
    Kuzume, Ayumi
    Kamura, Yuya
    Tabata, Rikako
    Tsushima, Takafumi
    Miura, Daisuke
    Narita, Kentaro
    Takeuchi, Masami
    Yamashita, Takeshi
    Takamatsu, Hiroyuki
    Matsue, Kosei
    BLOOD, 2022, 140 : 9277 - 9278
  • [8] Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies
    Saini, Kamal S.
    Tagliamento, Marco
    Lambertini, Matteo
    McNally, Richard
    Kelly, Adrianne
    Romano, Marco
    Chico, Isagani
    Jenson, Taylor
    Anderson, Steven M.
    Curigliano, Giuseppe
    de Azambuja, Evandro
    BLOOD, 2020, 136
  • [9] COVID-19 in hematological malignancy patients A protocol for a systematic review and meta-analysis
    Chen, Can
    Weng, Qianping
    Li, Yiwei
    Shi, Pengfei
    Qian, Shenxian
    MEDICINE, 2020, 99 (35)
  • [10] Hematological changes in patients with COVID-19
    Ye, Jieyu
    Jiao, Yingying
    Zhang, Yujiao
    Li, Zongpeng
    Zeng, Xiaoyuan
    Deng, Huixia
    Yang, Mo
    MOLECULAR MEDICINE REPORTS, 2020, 22 (06) : 4485 - 4491
12345